Table of Contents
Chapter 1. Global Animal Therapeutics and Diagnostics Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer's Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
Chapter 2. Executive Summary
2.1. Global Animal Therapeutics and Diagnostics Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product Type
2.3.2. By Animal Type
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Global Animal Therapeutics and Diagnostics Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Global Animal Therapeutics and Diagnostics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Animal Therapeutics and Diagnostics Market Size & Forecasts by Product Type 2022-2032
5.1. Animal Diagnostics Products
5.2. Animal Therapeutics Products
Chapter 6. Global Animal Therapeutics and Diagnostics Market Size & Forecasts by Animal Type 2022-2032
6.1. Companion Animals
6.2. Cattle
6.3. Pigs
6.4. Poultry
6.5. Sheep
Chapter 7. Global Animal Therapeutics and Diagnostics Market Size & Forecasts by Region 2022-2032
7.1. North America Animal Therapeutics and Diagnostics Market
7.1.1. U.S. Animal Therapeutics and Diagnostics Market
7.1.1.1. Product Type breakdown size & forecasts, 2022-2032
7.1.1.2. Animal Type breakdown size & forecasts, 2022-2032
7.1.2. Canada Animal Therapeutics and Diagnostics Market
7.2. Europe Animal Therapeutics and Diagnostics Market
7.2.1. U.K. Animal Therapeutics and Diagnostics Market
7.2.2. Germany Animal Therapeutics and Diagnostics Market
7.2.3. France Animal Therapeutics and Diagnostics Market
7.2.4. Spain Animal Therapeutics and Diagnostics Market
7.2.5. Italy Animal Therapeutics and Diagnostics Market
7.2.6. Rest of Europe Animal Therapeutics and Diagnostics Market
7.3. Asia-Pacific Animal Therapeutics and Diagnostics Market
7.3.1. China Animal Therapeutics and Diagnostics Market
7.3.2. India Animal Therapeutics and Diagnostics Market
7.3.3. Japan Animal Therapeutics and Diagnostics Market
7.3.4. Australia Animal Therapeutics and Diagnostics Market
7.3.5. South Korea Animal Therapeutics and Diagnostics Market
7.3.6. Rest of Asia Pacific Animal Therapeutics and Diagnostics Market
7.4. Latin America Animal Therapeutics and Diagnostics Market
7.4.1. Brazil Animal Therapeutics and Diagnostics Market
7.4.2. Mexico Animal Therapeutics and Diagnostics Market
7.4.3. Rest of Latin America Animal Therapeutics and Diagnostics Market
7.5. Middle East & Africa Animal Therapeutics and Diagnostics Market
7.5.1. Saudi Arabia Animal Therapeutics and Diagnostics Market
7.5.2. South Africa Animal Therapeutics and Diagnostics Market
7.5.3. Rest of Middle East & Africa Animal Therapeutics and Diagnostics Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Virbac S.A.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. ceva sante animale S.A.
8.3.3. C.H. Boehringer Sohn AG & Co. KG
8.3.4. Zoetis Inc
8.3.5. Sanofi S.A
8.3.6. Merck & Co., Inc.
8.3.7. Nutreco N.V.,
8.3.8. Eli Lilly and Company India Pvt. Ltd.
8.3.9. Bayer AG
8.3.10. Heska Corporation
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes